Vera Therapeutics, Inc.
Biotechnology
VicePresident,CommercialManufacturingOperations
Neural analysis suggests this role is
optimal for Executive candidates.
“Vice President, Commercial Manufacturing Operations at Vera Therapeutics, Inc.. Manage commercial manufacturing operations. Develop treatments for immunological diseases”
Industry & Context.
What They're Looking For.
Must Have
Ability to interact with all levels internally and externally, Ability to tailor communications to the audience, Attention to detail, Ability to move easily between hands-on work and strategic thinking, Ability to multitask and prioritize, Leadership skills, Demonstrated ability to influence and deliver results in a virtual (outsourced) environment
What You'll Do.
Manage commercial manufacturing operations
Develop treatments for immunological diseases
Advance treatments targeting disease source
Change standard of care for patients
Evaluate additional diseases for atacicept
Evaluate development of MAU868
Neutralize infection with BK virus
and grow finance group
How You'll Work.
Communication Scope
Tailor communications
Full Job Description
Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics’ mission is to advance treatments that target the source of disease in order to change the standard of care for patients. Vera Therapeutics’ lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell–mediated diseases. Vera Therapeutics is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109, and MAU868. For more information, please visit www.veratx.com. Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do—from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases. Position Summary: The Vice President, Manufacturing Operations will report to the SVP Product Development and Manufacturing (PD able to effectively interact with all levels internally and externally – able to tailor communications to the audience to achieve desired results. Attention to detail with abili
Applying for this Vice President, Commercial Manufacturing Operations role?
Most applicants get filtered before a human reads their resume. See if yours makes the cut.
How to Apply on Greenhouse
- Create a Greenhouse profile before applying — it saves time across multiple applications.
- Upload your resume as a PDF; the parser handles it better than Word.
- Answer all knockout questions carefully — wrong answers auto-reject before a human sees you.
- Enable email notifications to track application status in real time.
ANONYMOUS · UNFILTERED
What do employees actually say about Vera Therapeutics, Inc.?
Real rants from real employees. Read before you apply.